FXYD3 and thyroid gland carcinoma: In particular, autoantibodies recognizing a clone encoding an FXYD domain-containing ion transport regulator 3 FXYD3 were completely absent from the group of healthy controls and various benign conditions and demonstrated a significant difference in frequencies between groups of patients with thyroid cancer and healthy controls (Figure 2).